Table 2.

Odds ratios for purchases of psychotropic drugs by exit group and type of drug

	Pre-exit period	Peri-exit period	Post-exit period
	’-1 vs − 4’	’ + 1 vs − 1’	’ + 4 vs + 1’
Old-age retirement
Antidepressants
Downsizing	0.89 (0.80–0.98)	0.91 (0.85–0.98)	0.92 (0.84–1.02)
No downsizing	0.89 (0.84–0.95)	0.88 (0.84–0.91)	0.91 (0.86–0.96)
Sedatives
Downsizing	1.10 (1.00–1.20)	1.01 (0.95–1.07)*	1.08 (1.00–1.17)
No downsizing	1.04 (0.99–1.10)	0.95 (0.92–0.98)	1.08 (1.03–1.13)
Anxiolytics
Downsizing	1.10 (0.97–1.24)*	0.96 (0.89–1.04)	1.02 (0.92–1.14)
No downsizing	0.98 (0.91–1.06)	0.99 (0.95–1.04)	1.00 (0.94–1.07)
SA/DP
Antidepressants
Downsizing	1.19 (1.07–1.32)	0.88 (0.82–0.94)**	0.78 (0.70–0.86)
No downsizing	1.22 (1.14–1.32)	0.80 (0.76–0.84)	0.80 (0.75–0.86)
Sedatives
Downsizing	1.21 (1.09–1.35)	0.99 (0.93–1.06)**	1.00 (0.90–1.10)
No downsizing	1.22 (1.13–1.31)	0.89 (0.84–0.93)	0.94 (0.88–1.01)
Anxiolytics
Downsizing	1.25 (1.09–1.44)	0.93 (0.85–1.01)	0.92 (0.82–1.03)
No downsizing	1.25 (1.13–1.38)	0.90 (0.85–0.96)	0.93 (0.85–1.01)
Unemployment
Antidepressants
Downsizing	0.94 (0.78–1.14)*	0.90 (0.80–1.02)	0.77 (0.65–0.92)
No downsizing	0.76 (0.67–0.87)	0.80 (0.73–0.87)	0.70 (0.62–0.79)
Sedatives
Downsizing	0.92 (0.77–1.10)	0.86 (0.76–0.97)	0.86 (0.73–1.01)
No downsizing	0.91 (0.80–1.04)	0.87 (0.80–0.95)	1.00 (0.89–1.13)
Anxiolytics
Downsizing	0.81 (0.64–1.03)	0.93 (0.79–1.09)	0.96 (0.77–1.19)
No downsizing	0.92 (0.78–1.10)	0.88 (0.78–0.99)	0.84 (0.72–0.98)

Legend: Odds ratios were adjusted for calendar time and sociodemographic factors from the beginning of the 12-month period of exit, including sex, age, income, education, family status, type of living area, (* p < 0.05, ** p < 0.001 indicating a statistically significant difference in time trends between exposed and unexposed) (n = 235,430)